Interestingly, silencing GRP-R predominantly reduces AKT2 expression without affecting the expression of AKT1 or AKT3 isoform [13], thus demonstrating a more critical role of AKT2 in GRP-R-mediated neuroblastoma tumorigenesis. The gene discussed is AKT2; the disease is neuroblastoma.